Mineralys Therapeutics, Inc. (MLYS)
MLYS Stock Price Chart
Explore Mineralys Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze MLYS price movements and trends.
MLYS Company Profile
Discover essential business fundamentals and corporate details for Mineralys Therapeutics, Inc. (MLYS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
10 Feb 2023
Employees
51.00
Website
https://mineralystx.comCEO
Jon Congleton
Description
Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.
MLYS Financial Timeline
Browse a chronological timeline of Mineralys Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 10 Feb 2026
Upcoming earnings on 10 Nov 2025
EPS estimate is -$0.66.
Earnings released on 12 Aug 2025
EPS came in at -$0.66 surpassing the estimated -$0.78 by +15.38%.
Earnings released on 12 May 2025
EPS came in at -$0.79 surpassing the estimated -$1.02 by +22.55%.
Earnings released on 12 Feb 2025
EPS came in at -$0.98 surpassing the estimated -$1.00 by +2.00%.
Earnings released on 11 Nov 2024
EPS came in at -$1.13 falling short of the estimated -$0.83 by -36.14%.
Earnings released on 13 Aug 2024
EPS came in at -$0.83 falling short of the estimated -$0.73 by -13.70%.
Earnings released on 9 May 2024
EPS came in at -$0.70 falling short of the estimated -$0.68 by -2.94%.
Earnings released on 21 Mar 2024
EPS came in at -$0.61 surpassing the estimated -$0.85 by +28.24%.
Earnings released on 7 Nov 2023
EPS came in at -$0.57 surpassing the estimated -$0.72 by +20.83%.
Earnings released on 7 Aug 2023
EPS came in at -$0.31 surpassing the estimated -$0.83 by +62.65%.
Earnings released on 15 May 2023
EPS came in at -$0.51 surpassing the estimated -$0.71 by +28.17%.
Earnings released on 15 Mar 2023
EPS came in at -$1.74 falling short of the estimated $1.72 by -201.16%.
Earnings released on 10 Feb 2023
EPS came in at -$1.29K .
Earnings released on 30 Jun 2022
EPS came in at -$0.35 .
Earnings released on 31 Mar 2022
EPS came in at -$0.41 .
Earnings released on 31 Dec 2021
EPS came in at -$0.18 .
MLYS Stock Performance
Access detailed MLYS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.